MOLECULAR/CELLULAR BASIS OF CARDIAC ALLOGRAFT REJECTION
MOLECULAR/CELLULAR BASIS OF CARDIAC ALLOGRAFT REJECTION
批准号:
2068638
负责人:
Haval Shirwan
金额:
$11.1万
依托单位国家:
美国
项目类别:
财政年份:
1994
资助国家:
美国
项目状态:
已结题
起止时间:
1994-05-01 至 1999-04-30
关键词:
CD antigens T cell receptor T lymphocyte flow cytometry heart transplantation histocompatibility antigens homologous transplantation hybridomas laboratory rat major histocompatibility complex monoclonal antibody polymerase chain reaction synthetic peptide tissue /cell culture transplant rejection transplantation immunology
中文摘要
这项研究提案的主要目标是确定
参与免疫识别过程的分子成分
同种异体排斥反应。移植物排斥反应是由T细胞引起的。
受体通过克隆识别异种移植物的抗原-
表达的TCRs。这一识别过程的基础是形成
由TCR、MHC分子组成的三分子络合物
受体和/或供体类型),以及来自代谢的多肽
处理过的移植物抗原。免疫过程中这种复合体的形成
对移植物的反应启动了一系列细胞内和细胞间的
导致移植物被破坏的反应。因此,澄清
三分子复合体的性质和随后发生的事件
参与移植排斥反应不仅会拓宽我们的理解
但也可能提供一种手段来诱导嫁接-
特定容忍度。
这项建议的具体目标包括:
1.从中国分离的GIL对TCR谱系使用情况的表征
在不同品种的大鼠组合中进行的同种异体心脏移植
组织相容性抗原的范围。
2.建立特异性GIL的T细胞系和/或克隆
对移植物抗原的反应性及其在调节中的作用
心脏移植后的排斥反应。
3.识别作为移植物靶标的移植物抗原-
反应性T细胞及其在排斥反应中的作用分析
反应。
英文摘要
The primary objectives of this research proposal are to identify the
molecular components of the immune recognition process involved in
allograft rejection. Graft rejection is initiated by T cells of the
recipient recognizing antigens of the foreign graft through clonally-
expressed TCRs. The basis of this recognition process is the formation
of a trimolecular complex consisting of the TCR, MHC molecule (of the
recipient and/or donor type), and a peptide derived from metabolically
processed graft antigens. The formation of this complex during immune
response to the graft initiates a set of intra- and intercellular
reactions that result in destruction of the graft. Hence, elucidation
of the nature of the trimolecular complex and the subsequent events
involved in the graft rejection will not only broaden our understanding
of the rejection process, but may also provide a means to induce graft-
specific tolerance.
The Specific Aims of this proposal include:
1. Characterization of the TCR repertoire usage by GILs isolated from
cardiac allografts performed in rat strain combinations disparate for
range of histocompatibility antigens.
2. Establishment of T-cell lines and/or clones from GILs with specific
reactivity to graft antigens and examination of their role in mediating
cardiac graft rejection following adoptive transfer.
3. Identification of graft antigens that serve as targets for graft-
reactive T cells and the analysis of their role in the rejection
reaction.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
A novel immunomodulatory approach to overcome innate and adaptiveimmune barriers to islet transplantation
-
批准号:10289717
-
项目类别:
-
资助金额:$39.43万
-
财政年份:2018
-
负责人:Haval Shirwan
-
依托单位:
Developing a novel adjuvant system for therapeutic vaccines against lung cancer
-
批准号:9138899
-
项目类别:
-
资助金额:$22.5万
-
财政年份:2016
-
负责人:Haval Shirwan
-
依托单位:
Engineering pancreatic islets with TGβ protein to overcome rejection
-
批准号:9066573
-
项目类别:
-
资助金额:$18.75万
-
财政年份:2015
-
负责人:Haval Shirwan
-
依托单位:
Engineering pancreatic islets with TGβ protein to overcome rejection
-
批准号:8966928
-
项目类别:
-
资助金额:$22.5万
-
财政年份:2015
-
负责人:Haval Shirwan
-
依托单位:
ApoVax-SVN as a Novel Vaccine for Cancer Immunotherapy
-
批准号:7326239
-
项目类别:
-
资助金额:$32.83万
-
财政年份:2007
-
负责人:Haval Shirwan
-
依托单位:
A Novel Approach to Prevent and Treat Type 1 Diabetes
-
批准号:7096113
-
项目类别:
-
资助金额:$29.4万
-
财政年份:2004
-
负责人:Haval Shirwan
-
依托单位:
A NOVEL ADJUVANT FOR TUMQR VACCINATION
-
批准号:6735511
-
项目类别:
-
资助金额:$10.0万
-
财政年份:2004
-
负责人:Haval Shirwan
-
依托单位:
A Novel Approach to Prevent and Treat Type 1 Diabetes
-
批准号:6821845
-
项目类别:
-
资助金额:$29.4万
-
财政年份:2004
-
负责人:Haval Shirwan
-
依托单位:
APOPTOSIS:A MEANS OF IMMUNE REGULATION TO TREAT DIABETES
-
批准号:6352400
-
项目类别:
-
资助金额:$21.6万
-
财政年份:2001
-
负责人:Haval Shirwan
-
依托单位:
APOPTOSIS:A MEANS OF IMMUNE REGULATION TO TREAT DIABETES
-
批准号:6612650
-
项目类别:
-
资助金额:$21.6万
-
财政年份:2001
-
负责人:Haval Shirwan
-
依托单位:
Allograft Tolerance with Fas/FasL-Mediated Apoptosis
-
批准号:6621531
-
项目类别:
-
资助金额:$28.6万
-
财政年份:2001
-
负责人:Haval Shirwan
-
依托单位:
Allograft Tolerance with Fas/FasL-Mediated Apoptosis
-
批准号:6681866
-
项目类别:
-
资助金额:$28.6万
-
财政年份:2001
-
负责人:Haval Shirwan
-
依托单位:
Allograft Tolerance with Fas/FasL-Mediated Apoptosis
-
批准号:6828262
-
项目类别:
-
资助金额:$28.6万
-
财政年份:2001
-
负责人:Haval Shirwan
-
依托单位:
APOPTOSIS:A MEANS OF IMMUNE REGULATION TO TREAT DIABETES
-
批准号:6525243
-
项目类别:
-
资助金额:$21.6万
-
财政年份:2001
-
负责人:Haval Shirwan
-
依托单位:
Allograft Tolerance with Fas/FasL-Mediated Apoptosis
-
批准号:6434813
-
项目类别:
-
资助金额:$28.6万
-
财政年份:2001
-
负责人:Haval Shirwan
-
依托单位:
MOLECULAR/CELLULAR BASIS OF CARDIAC ALLOGRAFT REJECTION
-
批准号:2413634
-
项目类别:
-
资助金额:$11.32万
-
财政年份:1994
-
负责人:Haval Shirwan
-
依托单位:
MOLECULAR/CELLULAR BASIS OF CARDIAC ALLOGRAFT REJECTION
-
批准号:2068641
-
项目类别:
-
资助金额:$8.76万
-
财政年份:1994
-
负责人:Haval Shirwan
-
依托单位:
MOLECULAR/CELLULAR BASIS OF CARDIAC ALLOGRAFT REJECTION
-
批准号:2672187
-
项目类别:
-
资助金额:$2.05万
-
财政年份:1994
-
负责人:Haval Shirwan
-
依托单位:
MOLECULAR/CELLULAR BASIS OF CARDIAC ALLOGRAFT REJECTION
-
批准号:2068639
-
项目类别:
-
资助金额:$5.73万
-
财政年份:1994
-
负责人:Haval Shirwan
-
依托单位:
MOLECULAR/CELLULAR BASIS OF CARDIAC ALLOGRAFT REJECTION
-
批准号:2068640
-
项目类别:
-
资助金额:$4.24万
-
财政年份:1994
-
负责人:Haval Shirwan
-
依托单位:
海外基金